ME Therapeutics(AXSM)
NEW YORK, NY
BiotechnologyFocus: IO drugs against novel myeloid cell targets
ME Therapeutics is a life sciences company focused on IO drugs against novel myeloid cell targets.
Oncology
Funding Stage
PUBLIC
Total Funding
$1B
Open Jobs
1
Pipeline & Clinical Trials
Phone-Based Health Coaching Utilizing Lifestyle Action Plans
Type2 DiabetesMindfulness and Meditation-Based Relapse Prevention Program
Substance Use DisordersClinical Trials (1)
NCT07417579Mindfulness and Meditation-Based Relapse Prevention for Substance Use Disorders
N/ARevascularization
Coronary Syndrome, Acute, Non-ST Elevation, High Risk PatientsClinical Trials (1)
NCT06279663Management Tactics for Patients High Risk With Acute Coronary Syndrome Without ST Segment Elevation and Multivessel Coronary Artery Disease
N/AAutoimmunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Myalgic EncephalomyelitisClinical Trials (1)
NCT03254823Autoimmunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
N/AUnhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Post-Acute COVID-19 SyndromeClinical Trials (1)
NCT04806620Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
N/AFeasibility study of music-based mobile app
DementiaClinical Trials (1)
NCT06140342A Music-Based Mobile App for People Living With Alzheimer's Disease and Related Dementias (ADRD)
N/AMindful Self-Compassion Program
SchizophreniaClinical Trials (1)
NCT04144075Application of a Mindfulness and Self-Compassion Program in Patients With Schizophrenia. Randomized Controlled Trial.
N/AREADY To Stand Curriculum
Sex TraffickingClinical Trials (1)
NCT05988398Preventing Commercial Sexual Exploitation of Children
N/ADNA reports
Atopic DermatitisThe Myelin Disorders Biorepository Project
LeukodystrophyAmblyomin-X
Advanced CancerClinical Trials (1)
NCT03120130Study of Amblyomin-X in Advanced Solid Tumor
Phase 1Sodium heparin UQ Intravenous drug administration
HeparinClinical Trials (1)
NCT03125187Study With Heparin Sodium in Intravenous Administration
Phase 1Sodium Heparin UQ subcutaneous drug administration
HeparinClinical Trials (1)
NCT03113084Study With Heparin Sodium in Subcutaneous Administration
Phase 1AVX001
Actinic KeratosesClinical Trials (1)
NCT05164393Phase I/IIa Trial to Evaluate AVX001 Gel in Doses of 1% or 3% Compared With Vehicle Over Four Weeks of Field-directed Treatment Period in Adult Subjects With AK
Phase 1/2Nailner 2 in 1
OnychomycosisClinical Trials (1)
NCT02961634Study Efficacy and Safety in Comparative Use of Investigational Product Adjuvant Treatment in Onychomycosis
Phase 3Phase 3
Clinical Trials (1)
NCT02229942B-lymphocyte Depletion Using Rituximab in Chronic Fatigue Syndrome/ Myalgic Encephalopathy (CFS/ME). A Randomized Phase-III Study.
Phase 3Open Jobs (1)
Interview Prep Quick Facts
Founded: 2023
Portfolio: 13 clinical trials
SEC Filings: 2 available
Open Roles: 1 active job
Financials (FY2025)
Revenue
$271M441%
R&D Spend
$98M(36%)69%
Net Income
-$239MCash
$315M